Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox | BMC Cancer | Full Text

Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox | BMC Cancer | Full Text

Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox

Iron is required for cellular metabolism, and rapidly proliferating cancer cells require more of this essential nutrient. Therefore, iron regulation may well represent a new avenue for cancer therapy. We have ...

Authors:Shogo Amano, Seiji Kaino, Shuhei Shinoda, Hirofumi Harima, Toshihiko Matsumoto, Koichi Fujisawa, Taro Takami, Naoki Yamamoto, Takahiro Yamasaki and Isao Sakaida

Citation:BMC Cancer 2020 20:681

Content type:Research article

 

Published on: 22 July 2020

• ViewFull Text
 
• ViewPDF